BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8975357)

  • 1. [MALT-lymphoma--conservative therapy].
    Fischbach W
    Praxis (Bern 1994); 1996 Nov; 85(45):1455-8. PubMed ID: 8975357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Primary gastric lymphoma of the MALT type. The current knowledge on its etiology, therapy and prognosis].
    Fischbach W; Wilms K
    Strahlenther Onkol; 1995 Oct; 171(10):549-53. PubMed ID: 8571173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current aspects of pathogenesis, diagnosis and therapy of primary MALT stomach lymphomas].
    Fischbach W
    Z Gastroenterol; 1998 Apr; 36(4):307-12. PubMed ID: 9612929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicobacter pylori and lymphoproliferative disorders.
    Fischbach W
    Ital J Gastroenterol Hepatol; 1998 Oct; 30 Suppl 3():S299-303. PubMed ID: 10077759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Primary stomach lymphoma of the MALT type. Diagnosis and therapy. Gastrointestinal Lymphoma Study Group].
    Fischbach W; Böhm S
    Leber Magen Darm; 1994 May; 24(3):104, 107-10. PubMed ID: 8052089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Helicobacter pylori infection and gastrointestinal lymphomas].
    Fischbach W
    Schweiz Med Wochenschr; 1996 May; 126(19):826-9. PubMed ID: 8693307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
    Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S
    Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression of primary gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma after eradication of Helicobacter pylori.
    Falcó Jover G; Martínez Egea A; Sánchez Cuenca J; Onrubia Pintado J; García Lafuente N; Ruiz Gómez F; Coronas Planas M
    Rev Esp Enferm Dig; 1999 Aug; 91(8):541-8. PubMed ID: 10491486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of gastric lymphoma after stomach conserving treatment.
    Fischbach W
    Best Pract Res Clin Gastroenterol; 2010 Feb; 24(1):71-7. PubMed ID: 20206110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of gastric mucosa-associated lymphoid tissue lymphoma: Helicobacter pylori eradication and beyond.
    Montalban C; Norman F
    Expert Rev Anticancer Ther; 2006 Mar; 6(3):361-71. PubMed ID: 16503853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric MALT lymphoma and Helicobacter pylori.
    Wotherspoon AC
    Yale J Biol Med; 1996; 69(1):61-8. PubMed ID: 9041690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
    Chen LT; Lin JT; Tai JJ; Chen GH; Yeh HZ; Yang SS; Wang HP; Kuo SH; Sheu BS; Jan CM; Wang WM; Wang TE; Wu CW; Chen CL; Su IJ; Whang-Peng J; Cheng AL
    J Natl Cancer Inst; 2005 Sep; 97(18):1345-53. PubMed ID: 16174856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: follow-up study of 48 cases.
    Begum S; Sano T; Endo H; Kawamata H; Urakami Y
    J Med Invest; 2000 Feb; 47(1-2):36-46. PubMed ID: 10740978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric mucosal-associated lymphoid tissue lymphoma.
    Fischbach W
    Gastroenterol Clin North Am; 2013 Jun; 42(2):371-80. PubMed ID: 23639646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [MALT stomach lymphoma: is there a standardized therapy?].
    Fischbach W
    Z Gastroenterol; 1998 Dec; 36(12):1099-102. PubMed ID: 10025061
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up.
    Montalban C; Santon A; Boixeda D; Redondo C; Alvarez I; Calleja JL; de Argila CM; Bellas C
    Haematologica; 2001 Jun; 86(6):609-17. PubMed ID: 11418369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of CXCR3 expression in gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type for predicting responsiveness to Helicobacter pylori eradication.
    Yamamoto H; Nakamura T; Matsuo K; Tajika M; Kawai H; Ohmiya N; Niwa Y; Goto H; Nakamura S
    Cancer Sci; 2008 Sep; 99(9):1769-73. PubMed ID: 18616679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results of stomach-conserving therapy in gastric MALT lymphoma.
    Vrieling C; de Jong D; Boot H; de Boer JP; Wegman F; Aleman BM
    Radiother Oncol; 2008 Jun; 87(3):405-11. PubMed ID: 18343513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of low-grade gastric MALT lymphoma with Helicobacter pylori eradication. Follow-up of the histological and molecular response].
    Montalbán C; Manzanal A; Boixeda D; Redondo C; Alvarez I; Frutos B; Calleja JL; Sánchez-Godoy P; Bellas C
    Med Clin (Barc); 1998 Jan; 110(2):41-4. PubMed ID: 9534129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymph node involvement rate in low-grade gastric mucosa-associated lymphoid tissue lymphoma--too high to be neglected.
    Chang DK; Chin YJ; Kim JS; Jung HC; Kim CW; Song IS; Kim CY
    Hepatogastroenterology; 1999; 46(28):2694-700. PubMed ID: 10522067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.